Suppr超能文献

实践促进以支持初级保健医生接种新冠疫苗:一项随机临床试验。

Practice Facilitation to Support Primary Care Physicians With COVID-19 Vaccine Uptake: A Randomized Clinical Trial.

作者信息

Shuldiner Jennifer, Shah Noor-Ul-Huda, Bar-Ziv Stacey, Kaplan David M, Green Michael E, Bahniwal Ravninder, Bogoch Isaac I, Nowak Dominik Alex, Desveaux Laura, Taljaard Monica, Presseau Justin, Witteman Holly O, Lofters Aisha, Kiran Tara, Mauti Joe, Gill Simran, Ariyarajah Archchun, Chishtie Jawad, Tsang Denis, Tradrous Mina, Warshafsky Daniel, Hu Jia, Vohra-Miller Sabina, Ivers Noah

机构信息

Research and Innovation Institute, Women's College Hospital, Toronto, Ontario, Canada.

Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.

出版信息

JAMA Netw Open. 2025 May 1;8(5):e259967. doi: 10.1001/jamanetworkopen.2025.9967.

Abstract

IMPORTANCE

Recommendations by family physicians are associated with uptake of vaccines, but many family physicians had limited capacity to identify patients in their practice who might benefit from personalized vaccination counselling. Practice facilitation is an evidence-based method of supporting changes in primary care, but its role in supporting COVID-19 vaccination rates is unknown.

OBJECTIVE

To determine whether a multicomponent practice facilitation intervention would increase COVID-19 vaccine rates in the practices of family physicians with the largest number of unvaccinated patients.

DESIGN, SETTING, AND PARTICIPANTS: This 2-arm cluster-randomized clinical trial was conducted from November 15, 2021, to March 15, 2022, in Ontario, Canada's most populous province. Data were obtained from the provincial vaccine registry and were linked to routinely used administrative databases. Six hundred family physicians whose practices had the largest number of unvaccinated rostered patients in the province were randomized 1:1 to a practice facilitation intervention or a control group. Eighteen were excluded because they were not practicing family physicians. Follow-up was completed March 31, 2022, and data were analyzed from March 2023 to May 2024. The primary analysis was by intention-to-treat; unit of analysis was the patient.

INTERVENTION

Practice facilitators offered physicians support to identify, reach out to, and counsel their unvaccinated patients.

MAIN OUTCOMES AND MEASURES

Any vaccine dose during a 4-month follow-up interval among rostered patients older than 12 years was used to calculate the rate of doses per 100 patients. A modified robust Poisson regression method was used to analyze intervention effects; intervention effect was estimated as relative risk (RR) using least square means differences with 95% CIs.

RESULTS

Of 582 physicians included in the analysis (median age, 58 [IQR, 52-66] years; 426 [73.2%] male), 292 were randomized to the control arm and 290 to the intervention arm. Only 84 physicians (29.0%) in the intervention arm accepted assistance from a practice facilitator. Mean numbers of doses of COVID-19 vaccines per 100 patients were 49.8 (95% CI, 48.8-50.9) in the intervention arm and 50.2 (95% CI, 49.2-51.2) in the control arm (adjusted RR, 0.99; 95% CI, 0.96-1.02).

CONCLUSIONS AND RELEVANCE

In this study, practice facilitation to primary care clinics with high numbers of patients unvaccinated against COVID-19 was not associated with significant changes in vaccination uptake. Findings suggest the importance of ensuring that interventions target health services with high levels of both motivation and opportunity for improvement.

TRIAL REGISTRATION

ClinicalTrials.gov Identifier: NCT05099497.

摘要

重要性

家庭医生的建议与疫苗接种率相关,但许多家庭医生识别其诊所中可能从个性化疫苗接种咨询中受益的患者的能力有限。实践促进是一种支持初级保健变革的循证方法,但其在支持新冠疫苗接种率方面的作用尚不清楚。

目的

确定多成分实践促进干预措施是否会提高未接种疫苗患者数量最多的家庭医生诊所的新冠疫苗接种率。

设计、背景和参与者:这项双臂整群随机临床试验于2021年11月15日至2022年3月15日在加拿大人口最多的安大略省进行。数据从省级疫苗登记处获取,并与常规使用的行政数据库相关联。该省未接种疫苗的登记患者数量最多的600名家庭医生被1:1随机分配到实践促进干预组或对照组。18人被排除,因为他们不是执业家庭医生。随访于2022年3月31日完成,数据于2023年3月至2024年5月进行分析。主要分析采用意向性分析;分析单位是患者。

干预措施

实践促进者为医生提供支持,以识别、联系并为其未接种疫苗的患者提供咨询。

主要结局和测量指标

在4个月的随访期内,12岁以上登记患者中接种任何一剂疫苗的情况用于计算每100名患者的接种率。采用改良的稳健泊松回归方法分析干预效果;干预效果以相对风险(RR)估计,使用最小二乘均数差异和95%置信区间。

结果

纳入分析的582名医生(中位年龄58岁[四分位间距,52 - 66岁];426名[73.2%]为男性)中,292名被随机分配到对照组,290名被随机分配到干预组。干预组中只有84名医生(29.0%)接受了实践促进者的帮助。干预组每100名患者的新冠疫苗接种平均剂量为49.8(95%置信区间,48.8 - 50.9),对照组为50.2(95%置信区间,49.2 - 51.2)(调整后RR,0.99;95%置信区间,0.96 - 1.02)。

结论和相关性

在本研究中,对新冠疫苗未接种患者数量较多的初级保健诊所进行实践促进与疫苗接种率的显著变化无关。研究结果表明,确保干预措施针对既有积极性又有改进机会的高水平卫生服务的重要性。

试验注册

ClinicalTrials.gov标识符:NCT05099497。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1898/12079287/7e44d4a3f5b1/jamanetwopen-e259967-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验